Patient Care



The Department of Neurosurgery and Neuro-oncology in Sun Yat-Sen University Cancer Center (SYSUCC) of was founded with a commitment to patient care, education and research in year 2000. SYSUCC was then one of the earliest tumor centers in China, which provided neurosurgical therapy for patients with central nervous system (CNS) tumors. Under the direction of Dr. Chen Zhongping, professor and chairman of the department, the department of Neurosurgery and Neuro-oncology has become one of the best medical units in China providing both neurosurgical therapy and chemotherapy, and is now composed of 2 wards including 60 beds.  A team including 11 neurosurgeons and 2 neuro-oncologists are performing approximately 1400 procedures annually.


Medical Care

Our department is committed to the diagnosis and treatment of malignant and benign CNS tumors, including glioma, meningioma, pituitary, tumor, shwannoma, craniopharyngioma, hemangioblastoma, medulloblastoma, germinoma, primary central nervous system lymphoma and metastatic brain tumors. We take a team approach to provide the most advanced treatment with the least impact on the patients’ body, emphasizing that each patient is unique requiring an individualized comprehensive management. As one of the best medical care units for managing patients with glioma in China, our department struggle for standardized comprehensive treatment of not only glioma but also other CNS tumors. The neurosurgeons are able to perform a full range of procedures applying modern microsurgical and image guided techniques to the removal of complex and deep seated tumors involving the CNS, such as operable brain stem lesions, intramedullary tumors in upper cervical segment, petroclival tumors, jugular foramen tumors, and tumors located at the thalamus. As one of the earliest nerooncology units and also one of the medical centers for training neurooncologists in China, our department provides individual chemotherapy strategy based on histopathology result and the molecular biological characteristics. The CNS tumor multidisciplinary team (MDT) of SYSUCC comprised of neurosurgeons, radiation oncologists, medical oncologists, radiologists, pathologists and other specialists, meets weekly to review tumor cases and create a comprehensive treatment plan for them.


 Our surgeons and scientists perform unique, national funded research into methods for improving clinical outcomes; we initiate and participate in about 5 clinical trials about the treatment of CNS tumors. Thanks to the State Key Laboratory of Oncology in Southern China, the research team led by Dr. Chen Zhongping has been working on the molecular mechanism of radiotherapy and/or chemotherapy resistance of brain glioma, and also on the vascular mimicry phenomenon in giloma. In the last decade, 8 research projects have been supported by the National Natural Science Fund, and more than 200 manuscripts have been published.


In order to share minds of the neurosurgeon and neuroocologists in China, the journal "Chinese Journal of neuro-oncology" began to be published in 2003 (Dr. Chen Zhongping as editor). Also thanks to Dr. Chen Zhongping’s effort several organizations for neurooncologists were founded in China, including Chinese Society for Neurooncology (CSNO) founded in 2004 and the CNS tumor Professional Committee of the Guangzhou anti-cancer association established in 2001.

Where are we | Contact us|

Copyright:Sun Yat-sen University Cancer Center Designed by Wanhu.